Novartis
NVS
#58
Rank
NZ$351.34 B
Marketcap
$175.68
Share price
-0.17%
Change (1 day)
11.40%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$176.41 Billion

According to Novartis's latest financial reports the company's total assets are NZ$176.41 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novartis - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$158.04 B-14.57%
2022-12-31NZ$184.99 B-4.12%
2021-12-31NZ$192.95 B8.96%
2020-12-31NZ$177.09 B0.76%
2019-12-31NZ$175.75 B-19.01%
2018-12-31NZ$217.00 B15.81%
2017-12-31NZ$187.38 B-0.25%
2016-12-31NZ$187.85 B-2.27%
2015-12-31NZ$192.21 B20.11%
2014-12-31NZ$160.03 B4.16%
2013-12-31NZ$153.63 B1.77%
2012-12-31NZ$150.96 B0.28%
2011-12-31NZ$150.54 B-5.82%
2010-12-31NZ$159.84 B21.56%
2009-12-31NZ$131.49 B-2.54%
2008-12-31NZ$134.92 B36.98%
2007-12-31NZ$98.50 B2.04%
2006-12-31NZ$96.53 B14.29%
2005-12-31NZ$84.46 B14.83%
2004-12-31NZ$73.55 B-3.04%
2003-12-31NZ$75.86 B-11.82%
2002-12-31NZ$86.03 B-11.36%
2001-12-31NZ$97.06 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$200.28 B 13.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$374.00 B 112.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$303.81 B 72.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$237.03 B 34.36%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$132.38 B-24.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$71.15 B-59.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$159.62 B-9.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$126.71 B-28.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$177.80 B 0.79%๐Ÿ‡ฌ๐Ÿ‡ง UK